The COVID-19 pandemic has had some negative physical and social impacts on the overall well-being of people with Parkinson’s disease, a new study highlights. Therefore, it’s important for clinicians to help patients get social support, not just address physical symptoms of the disease as pandemic-related restrictions ease, researchers wrote…
Rates of Parkinson’s disease progression and treatment response may differ among patients depending on whether the disease primarily affects the dominant or nondominant side of the body, a small study of typing skills in patients new to dopaminergic therapy suggests. “These findings suggest that the relationship between side of…
Regular physical exercise helps to improve balance and mobility in people with mild to moderate Parkinson’s disease, an analysis of published studies reports. Best results, in terms of this easing in disease motor symptoms, were seen with “consistent and sustained” participation in exercise sessions. “The findings of our…
Men who have played American football are at increased risk of developing Parkinson’s disease. That’s according to the study, “American Football Play and Parkinson Disease Among Men,” published in JAMA Network Open. “I would say that I was surprised by the strength of the effect…
Using machine learning to analyze a patient-derived cell model may help to identify different molecular subtypes of Parkinson’s disease, a new study shows. “Using a model of the patient’s own neurons, and combining this with large numbers of images, we generated an algorithm to classify certain subtypes – a…
People with Parkinson’s disease are nearly twice as likely to experience delirium — acute confusion and difficulty with attention — after surgery. They also tend to have longer hospital stays and higher medical costs following surgery, according to a study, “Association of Postoperative Delirium and Parkinson…
People with Parkinson’s disease who are hospitalized for fractures due to falls or other traumatic injuries are not likely to stop being prescribed medications that can increase a fall risk, a study reports. Findings were similar in patients hospitalized for other Parkinson’s-related reasons, like pneumonia or urinary tract infections.
A group of immune cells called border-associated macrophages, or BAMs, have a central role in driving inflammation in the brain in Parkinson’s disease, a new study reports. “The results point to a critical role for BAMs in neuroinflammatory responses and highlight the need for disease-modifying therapeutic targeting of BAMs…
Digital tools, such as wearable devices and video calls, may help people with Parkinson’s disease in managing their nutrition — but barriers will need to be overcome before these tools can be used optimally by patients and caregivers. That’s according to the study, “The Facilitators and…
The U.S. Food and Drug Administration (FDA) has given Aspen Neuroscience clearance to launch a clinical trial of ANPD001, an experimental stem cell therapy designed to replace the nerve cells that are lost in Parkinson’s disease. As planned, the open-label Phase 1/2a trial will test the safety,…
Get regular updates to your inbox.
